In Model 3, participants in the T3 group of SHR had a 88% higher risk of all-cause mortality compared to those in the T1 group (HR: 1.88, 95% CI: 1.48-2.39) after controlling for age, sex, BMI, DM, hypertension, prior CVD, hyperlipemia, prior CAD, current smoking, hs-CRP, cTNI, Scr, UA, D-D, ACEI/ARB, GS, PPCI. Here, CRP is linked to familial hyperlipidemia.